Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000171

Chairperson & CEO sold 9,500 shares at an average $582.76 ($5,536,235)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-23 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-23 Sale : show line 2 in the form 10b5-1 −200 $577.68 $115,535 333,743 I
2026-10-23 Sale : show line 3 in the form 10b5-1 −700 $578.80 $405,160 333,043 I
2026-10-23 Sale : show line 4 in the form 10b5-1 −1,038 $579.74 $601,773 332,005 I
2026-10-23 Sale : show line 5 in the form 10b5-1 −1,017 $580.78 $590,653 330,988 I
2026-10-23 Sale : show line 6 in the form 10b5-1 −1,650 $581.82 $960,006 329,338 I
2026-10-23 Sale : show line 7 in the form 10b5-1 −1,732 $582.78 $1,009,367 327,606 I
2026-10-23 Sale : show line 8 in the form 10b5-1 −427 $583.83 $249,297 327,179 I
Open-market sales · 9,500 sh · avg $582.76 · $5,536,235

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-23 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option −9,500 166,910 I
Loading xslF345X06/primarydocument.xml…